What is the primary purpose of this filing?

This filing is a Form 10-Q, which is a quarterly report required by the U.S. Securities and Exchange Commission (SEC). It provides an update on the company's financial performance and other material information for the quarter ended June 30, 2005.

Is Boston Scientific Corporation considered a large company based on this filing?

Yes, Boston Scientific Corporation is identified as an 'accelerated filer.' This designation typically applies to companies with a public float of $75 million or more and a reporting history, indicating a significant size and market presence.

How many shares of common stock were outstanding at the end of the reporting period?

As of June 30, 2005, Boston Scientific Corporation had 820,188,075 shares of common stock outstanding.

Does the company have a history of timely filings?

Yes, the filing explicitly states that Boston Scientific Corporation has filed all reports required by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months, demonstrating a consistent record of regulatory compliance.

BSX 10-Q Quarterly Report Q2 FY2005 — Revenue, Net Income, EPS

Summary

Boston Scientific Corporation's (BSX) Form 10-Q for the quarter ended June 30, 2005, reveals a company actively navigating its operational and financial landscape. While the filing primarily serves as a routine update, it confirms BSX's status as an accelerated filer, indicating significant market presence and reporting compliance. The company has filed all required reports for the preceding 12 months, demonstrating a commitment to transparency and regulatory adherence, which is crucial for investor confidence.

Key Highlights

1Boston Scientific Corporation is operating as an accelerated filer, meeting all reporting requirements for the past 12 months.
2As of June 30, 2005, the company had 820,188,075 shares of common stock outstanding.
3The report covers the quarterly period ended June 30, 2005.
4BSX is registered in Delaware, with its principal executive offices located in Natick, Massachusetts.
5The filing confirms the company's fiscal identity and legal structure.
6The report is a standard 10-Q filing, indicating regular disclosure practices.

BOSTON SCIENTIFIC CORP Quarterly Report for Q2 Ended Jun 30, 2005

Summary

Key Highlights

Frequently Asked Questions